Prioritizing genes associated with brain disorders by leveraging enhancer-promoter interactions in diverse neural cells and tissues

被引:1
|
作者
Zhao, Xingzhong [1 ,2 ,3 ,4 ]
Song, Liting [1 ,2 ,3 ,4 ]
Yang, Anyi [1 ,2 ,3 ,4 ]
Zhang, Zichao [1 ,2 ,3 ,4 ]
Zhang, Jinglong [1 ,2 ,3 ,4 ]
Yang, Yucheng T. [1 ,2 ,3 ,4 ]
Zhao, Xing-Ming [1 ,2 ,3 ,4 ,5 ,6 ]
机构
[1] Fudan Univ, Inst Sci & Technol Brain Inspired Intelligence, 220 Handan Rd, Shanghai 200433, Peoples R China
[2] Fudan Univ, Dept Neurol, Zhongshan Hosp, 220 Handan Rd, Shanghai 200433, Peoples R China
[3] Fudan Univ, MOE Key Lab Computat Neurosci & Brain Inspired Int, Shanghai 200433, Peoples R China
[4] Fudan Univ, MOE Frontiers Ctr Brain Sci, Shanghai 200433, Peoples R China
[5] Fudan Univ, Inst Brain Sci, State Key Lab Med Neurobiol, Shanghai 200032, Peoples R China
[6] Internatioal Human Phenome Inst Shanghai, Shanghai 200433, Peoples R China
基金
上海市自然科学基金; 中国国家自然科学基金;
关键词
Cis-regulatory element; Enhancer-promoter interaction; Bain disorder; Heritability; GENOME-WIDE ASSOCIATION; PARTITIONING HERITABILITY; SYSTEMATIC METAANALYSES; TRANSCRIPTION FACTORS; UNIFIED ARCHITECTURE; ALZHEIMER-DISEASE; RISK VARIANTS; CHROMATIN; IDENTITY; LANDSCAPE;
D O I
10.1186/s13073-023-01210-6
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
BackgroundPrioritizing genes that underlie complex brain disorders poses a considerable challenge. Despite previous studies have found that they shared symptoms and heterogeneity, it remained difficult to systematically identify the risk genes associated with them.MethodsBy using the CAGE (Cap Analysis of Gene Expression) read alignment files for 439 human cell and tissue types (including primary cells, tissues and cell lines) from FANTOM5 project, we predicted enhancer-promoter interactions (EPIs) of 439 cell and tissue types in human, and examined their reliability. Then we evaluated the genetic heritability of 17 diverse brain disorders and behavioral-cognitive phenotypes in each neural cell type, brain region, and developmental stage. Furthermore, we prioritized genes associated with brain disorders and phenotypes by leveraging the EPIs in each neural cell and tissue type, and analyzed their pleiotropy and functionality for different categories of disorders and phenotypes. Finally, we characterized the spatiotemporal expression dynamics of these associated genes in cells and tissues.ResultsWe found that identified EPIs showed activity specificity and network aggregation in cell and tissue types, and enriched TF binding in neural cells played key roles in synaptic plasticity and nerve cell development, i.e., EGR1 and SOX family. We also discovered that most neurological disorders exhibit heritability enrichment in neural stem cells and astrocytes, while psychiatric disorders and behavioral-cognitive phenotypes exhibit enrichment in neurons. Furthermore, our identified genes recapitulated well-known risk genes, which exhibited widespread pleiotropy between psychiatric disorders and behavioral-cognitive phenotypes (i.e., FOXP2), and indicated expression specificity in neural cell types, brain regions, and developmental stages associated with disorders and phenotypes. Importantly, we showed the potential associations of brain disorders with brain regions and developmental stages that have not been well studied.ConclusionsOverall, our study characterized the gene-enhancer regulatory networks and genetic mechanisms in the human neural cells and tissues, and illustrated the value of reanalysis of publicly available genomic datasets.
引用
收藏
页数:20
相关论文
共 8 条
  • [1] Prioritizing genes associated with brain disorders by leveraging enhancer-promoter interactions in diverse neural cells and tissues
    Xingzhong Zhao
    Liting Song
    Anyi Yang
    Zichao Zhang
    Jinglong Zhang
    Yucheng T. Yang
    Xing-Ming Zhao
    Genome Medicine, 15
  • [2] Integration of Enhancer-Promoter Interactions with GWAS Summary Results Identifies Novel Schizophrenia-Associated Genes and Pathways
    Wu, Chong
    Pan, Wei
    GENETICS, 2018, 209 (03) : 699 - 709
  • [3] Leveraging putative enhancer-promoter interactions to investigate two-way epistasis in Type 2 Diabetes GWAS
    Manduchi, Elisabetta
    Chesi, Alessandra
    Hall, Molly A.
    Grant, Struan F. A.
    Moore, Jason H.
    PACIFIC SYMPOSIUM ON BIOCOMPUTING 2018 (PSB), 2018, : 548 - 558
  • [4] A genome-wide nucleosome-resolution map of promoter-centered interactions in human cells corroborates the enhancer-promoter looping model
    Golov, Arkadiy K.
    Gavrilov, Alexey A.
    Kaplan, Noam
    Razin, Sergey V.
    ELIFE, 2024, 12
  • [5] Biallelic non-productive enhancer-promoter interactions precede imprinted expression of Kcnk9 during mouse neural commitment
    Rojas, Cecilia Rengifo
    Cercy, Jil
    Perillous, Sophie
    Gonthier-Gueret, Celine
    Montibus, Bertille
    Maupetit-Mehouas, Stephanie
    Espinadel, Astrid
    Dupre, Marylou
    Hong, Charles C.
    Hata, Kenichiro
    Nakabayashi, Kazuhiko
    Plagge, Antonius
    Bouschet, Tristan
    Arnaud, Philippe
    Vaillant, Isabelle
    Court, Franck
    HUMAN GENETICS AND GENOMICS ADVANCES, 2024, 5 (02):
  • [6] Vorinostat-induced acetylation of RUNX3 reshapes transcriptional profile through long-range enhancer-promoter interactions in natural killer cells
    Lee, Eun-Chong
    Kim, Kyungwoo
    Jung, Woong-Jae
    Kim, Hyoung-Pyo
    BMB REPORTS, 2023, 56 (07) : 398 - 403
  • [7] An H2A histone isotype regulates estrogen receptor target genes by mediating enhancer-promoter-3′-UTR interactions in breast cancer cells
    Su, Chia-Hsin
    Tzeng, Tsai-Yu
    Cheng, Ching
    Hsu, Ming-Ta
    NUCLEIC ACIDS RESEARCH, 2014, 42 (05) : 3073 - 3088
  • [8] H3K79me2/3 controls enhancer-promoter interactions and activation of the pan-cancer stem cell marker PROM1/CD133 in MLL-AF4 leukemia cells
    Godfrey, Laura
    Crump, Nicholas T.
    O'Byrne, Sorcha
    Lau, I-Jun
    Rice, Siobhan
    Harman, Joe R.
    Jackson, Thomas
    Elliott, Natalina
    Buck, Gemma
    Connor, Christopher
    Thorne, Ross
    Knapp, David J. H. F.
    Heidenreich, Olaf
    Vyas, Paresh
    Menendez, Pablo
    Inglott, Sarah
    Ancliff, Philip
    Geng, Huimin
    Roberts, Irene
    Roy, Anindita
    Milne, Thomas A.
    LEUKEMIA, 2021, 35 (01) : 90 - 106